Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Volitionrx (VNRX) Short-Term Debt repayments (2019 - 2022)

Historic Short-Term Debt repayments for Volitionrx (VNRX) over the last 4 years, with Q3 2022 value amounting to -$10679.0.

  • Volitionrx's Short-Term Debt repayments rose 2652.4% to -$10679.0 in Q3 2022 from the same period last year, while for Sep 2022 it was -$49597.0, marking a year-over-year increase of 1392.25%. This contributed to the annual value of -$552534.0 for FY2016, which is 15468.85% down from last year.
  • Volitionrx's Short-Term Debt repayments amounted to -$10679.0 in Q3 2022, which was up 2652.4% from -$11251.0 recorded in Q2 2022.
  • Over the past 5 years, Volitionrx's Short-Term Debt repayments peaked at $35678.0 during Q1 2019, and registered a low of -$14722.0 during Q1 2021.
  • For the 4-year period, Volitionrx's Short-Term Debt repayments averaged around -$7125.5, with its median value being -$13435.5 (2020).
  • As far as peak fluctuations go, Volitionrx's Short-Term Debt repayments plummeted by 579.41% in 2021, and later surged by 2652.4% in 2022.
  • Quarter analysis of 4 years shows Volitionrx's Short-Term Debt repayments stood at $35678.0 in 2019, then crashed by 138.51% to -$13738.0 in 2020, then fell by 5.79% to -$14534.0 in 2021, then rose by 26.52% to -$10679.0 in 2022.
  • Its Short-Term Debt repayments was -$10679.0 in Q3 2022, compared to -$11251.0 in Q2 2022 and -$13133.0 in Q1 2022.